DE60303925D1 - Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz - Google Patents

Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz

Info

Publication number
DE60303925D1
DE60303925D1 DE60303925T DE60303925T DE60303925D1 DE 60303925 D1 DE60303925 D1 DE 60303925D1 DE 60303925 T DE60303925 T DE 60303925T DE 60303925 T DE60303925 T DE 60303925T DE 60303925 D1 DE60303925 D1 DE 60303925D1
Authority
DE
Germany
Prior art keywords
male
treatment
compositions
female impotence
female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60303925T
Other languages
English (en)
Other versions
DE60303925T2 (de
Inventor
Ezio Bombardelli
Paolo Morazzoni
Antonella Riva
Roberto Seghizzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11449866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60303925(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena SpA filed Critical Indena SpA
Publication of DE60303925D1 publication Critical patent/DE60303925D1/de
Application granted granted Critical
Publication of DE60303925T2 publication Critical patent/DE60303925T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE60303925T 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz Expired - Lifetime DE60303925T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002MI000990A ITMI20020990A1 (it) 2002-05-10 2002-05-10 Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020990 2002-05-10
PCT/EP2003/004528 WO2003094943A1 (en) 2002-05-10 2003-04-30 Formulations useful in the treatment of male and female impotence

Publications (2)

Publication Number Publication Date
DE60303925D1 true DE60303925D1 (de) 2006-05-04
DE60303925T2 DE60303925T2 (de) 2006-08-24

Family

ID=11449866

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60303925T Expired - Lifetime DE60303925T2 (de) 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz
DE60325657T Expired - Lifetime DE60325657D1 (de) 2002-05-10 2003-04-30 Formulierungen zur Behandlung von männlicher und weiblicher Impotenz

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60325657T Expired - Lifetime DE60325657D1 (de) 2002-05-10 2003-04-30 Formulierungen zur Behandlung von männlicher und weiblicher Impotenz

Country Status (19)

Country Link
US (1) US7128932B2 (de)
EP (2) EP1503775B1 (de)
JP (1) JP4603351B2 (de)
KR (1) KR20040102212A (de)
CN (2) CN100356935C (de)
AT (2) ATE319466T1 (de)
AU (1) AU2003240478B8 (de)
CA (1) CA2485264A1 (de)
DE (2) DE60303925T2 (de)
DK (2) DK1503775T3 (de)
ES (2) ES2259139T3 (de)
HK (1) HK1085374A1 (de)
IL (2) IL165081A (de)
IT (1) ITMI20020990A1 (de)
NO (2) NO332805B1 (de)
PT (2) PT1658854E (de)
RU (2) RU2313357C2 (de)
SI (2) SI1658854T1 (de)
WO (1) WO2003094943A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6952691B2 (en) * 2002-02-01 2005-10-04 International Business Machines Corporation Method and system for searching a multi-lingual database
WO2005034923A1 (en) * 2003-10-10 2005-04-21 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
WO2006021930A2 (en) * 2004-08-25 2006-03-02 Femi-X A/S Aphrodisiac herbal composition for a female comprising epimedium grandiflorum, turnera diffusa var. aphrodisiaca, ilex paraguariensis and smilax spp
KR100660116B1 (ko) * 2005-01-26 2006-12-20 (주)포메디 홍삼 및 대두를 주성분으로 포함하는 복합 한방 제제를유효성분으로 함유하는 성기능 개선용 조성물
US20070042054A1 (en) * 2005-04-20 2007-02-22 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
EP1932531A1 (de) * 2006-12-11 2008-06-18 Finzelberg GmbH & Co. KG Spezialextrakt und seine Verwendung zur Hemmung des Abbaus von cyclischem Guanosinmonophosphat (cGMP)
US8362088B2 (en) * 2006-12-14 2013-01-29 Warnock W Matthew Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient
US9918489B2 (en) * 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
DK2477633T3 (da) * 2009-09-17 2013-09-30 Tradapharma Sagl Kosttilskud til stimulering af den mandlige seksualfunktion
ES2386859B1 (es) * 2011-02-07 2013-03-22 Eduardo Antonio Gómez De Diego Composición natural para aumentar el vigor.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
ITLI20110007A1 (it) * 2011-09-10 2013-03-11 Lloyds Internat Credit Llc Una innovativa composizione naturale efficace per la cura dell'impotenza
TW201420745A (zh) * 2012-11-26 2014-06-01 Tian-De Li 擴充男性海綿體的複方精油
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
US10016477B1 (en) 2015-01-13 2018-07-10 Roger Yomba Ngue Natural composition
IT201700115753A1 (it) * 2017-10-13 2019-04-13 Cristalfarma S R L Integratore per attenuare i disturbi nella donna causati dall’invecchiamento
EP3560488A1 (de) * 2018-04-24 2019-10-30 Procare Health Iberia, S.L. Zusammensetzung zur behandlung weiblicher sexueller dysfunktion
WO2022027122A1 (en) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions with cannabinoids of cannabis sativa for treating erectile and sexual dysfunction
IT202100031175A1 (it) * 2021-12-13 2023-06-13 Anvest Group S R L Composizione per il trattamento della disfunzione erettile
GR1010519B (el) * 2022-07-04 2023-08-10 Νικολαος Τυμπανιδης Καταπινομενο σκευασμα για τονωση της ζωτικοτητας, της αντοχης και της γενικοτερης ευεξιας των ανδρων

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084746A (zh) * 1992-11-25 1994-04-06 王立本 防治性病的特效壮阳药液及其制作方法
KR0148511B1 (ko) * 1993-09-14 1998-11-02 최형기 성신경과민증 예방 및 치료용 의약조성물
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
CN1141185A (zh) * 1996-02-16 1997-01-29 范凯 保健药酒
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
JP3727538B2 (ja) * 1998-08-03 2005-12-14 イー ホウィーラー，ロナルド 前立腺配合物
JP2003500452A (ja) * 1999-05-27 2003-01-07 アーマディーロ・ファーマシューティカルス・インコーポレーテッド 天然資源から抽出した生物活性物質の医薬製剤
RU2153347C1 (ru) * 1999-06-04 2000-07-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения импотенции
US6803060B2 (en) * 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
US6444237B1 (en) * 2001-09-13 2002-09-03 Pamela A. Heleen Herbal composition for enhancing sexual response
US20030068391A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H. Ingestible nerve and circulatory nutritional formulation

Also Published As

Publication number Publication date
DK1503775T3 (da) 2006-07-17
KR20040102212A (ko) 2004-12-03
PT1503775E (pt) 2006-07-31
ATE418995T1 (de) 2009-01-15
PT1658854E (pt) 2009-03-23
RU2007108559A (ru) 2008-09-20
RU2004132833A (ru) 2005-06-27
SI1658854T1 (sl) 2009-04-30
AU2003240478B2 (en) 2007-05-31
IL192138A0 (en) 2008-12-29
EP1658854A3 (de) 2007-04-25
US7128932B2 (en) 2006-10-31
ATE319466T1 (de) 2006-03-15
WO2003094943A1 (en) 2003-11-20
EP1503775B1 (de) 2006-03-08
IL165081A (en) 2009-09-22
JP4603351B2 (ja) 2010-12-22
ITMI20020990A1 (it) 2003-11-10
US20050220905A1 (en) 2005-10-06
EP1658854B1 (de) 2008-12-31
RU2440127C2 (ru) 2012-01-20
SI1503775T1 (sl) 2006-06-30
EP1503775A1 (de) 2005-02-09
NO20044855L (no) 2004-11-08
NO332805B1 (no) 2013-01-14
IL165081A0 (en) 2005-12-18
CN100356935C (zh) 2007-12-26
DK1658854T3 (da) 2009-03-09
ITMI20020990A0 (it) 2002-05-10
DE60303925T2 (de) 2006-08-24
JP2005529915A (ja) 2005-10-06
DE60325657D1 (de) 2009-02-12
AU2003240478B8 (en) 2009-08-06
CA2485264A1 (en) 2003-11-20
ES2318406T3 (es) 2009-05-01
ES2259139T3 (es) 2006-09-16
PL371674A1 (en) 2005-06-27
CN101164559A (zh) 2008-04-23
IL192138A (en) 2010-12-30
EP1658854A2 (de) 2006-05-24
NO20120620L (no) 2004-11-08
RU2313357C2 (ru) 2007-12-27
HK1085374A1 (en) 2006-08-25
CN1652806A (zh) 2005-08-10
AU2003240478A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
IL192138A0 (en) Formulations useful in the treatment of male and female impotence
DE60317946D1 (de) Nützliche Formulierungen zur Behandlung von männlicher und weiblicher Impotenz
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
UA110463C2 (ru) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я
TW200505429A (en) Pharmaceutical composition
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
NO20061223L (no) Orale sammensetninger for behandlingen av cellulitt
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
GR1007337B (el) Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινη
ATE372771T1 (de) Verwendung von 1-thiadibenzo e,h azulenen zur herstellung von pharmazeutischen formulierungen für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems
Kim et al. Treatment of burning mouth syndrome: a report of 2 cases
DE602004013695D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie
GEU20041132Y (en) Means for Treatment of Oral Cavity Diseases.
UA39044A (uk) Склад для лікування хвороб пародонта
RU2000106783A (ru) Препарат для лечения пародонтоза

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC